Literature DB >> 10464224

A unique alpha-1,3 mannosyltransferase of the pathogenic fungus Cryptococcus neoformans.

T L Doering1.   

Abstract

The major virulence factor of the pathogenic fungus Cryptococcus neoformans is an extensive polysaccharide capsule which surrounds the cell. Almost 90% of the capsule is composed of a partially acetylated linear alpha-1,3-linked mannan substituted with D-xylose and D-glucuronic acid. A novel mannosyltransferase with specificity appropriate for a role in the synthesis of this glucuronoxylomannan is active in cryptococcal membranes. This membrane-associated activity transfers mannose in vitro from GDP-mannose to an alpha-1, 3-dimannoside acceptor, forming a second alpha-1,3 linkage. Product formation by the transferase is dependent on protein, time, temperature, divalent cations, and each substrate. It is not affected by amphomycin or tunicamycin but is inhibited by GDP and mannose-1-phosphate. The described activity is not detectable in the model yeast Saccharomyces cerevisiae, consistent with the absence of a similar polysaccharide structure in that organism. A second mannosyltransferase from C. neoformans membranes adds mannose in alpha-1,2 linkage to the same dimannoside acceptor. The two activities differ in pH optimum and cation preference. While the alpha-1,2 transferase does not have specificity appropriate for a role in glucuronoxylomannan synthesis, it may participate in production of mannoprotein components of the capsule. This study suggests two new targets for antifungal drug discovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464224      PMCID: PMC94059     

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  32 in total

1.  Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.

Authors:  E S Jacobson; D J Ayers; A C Harrell; C C Nicholas
Journal:  J Bacteriol       Date:  1982-06       Impact factor: 3.490

2.  Studies on capsule synthesis of Cryptococcus neoformans.

Authors:  F Bergman
Journal:  Sabouraudia       Date:  1965-02

3.  Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans.

Authors:  C W White; R Cherniak; E S Jacobson
Journal:  J Med Vet Mycol       Date:  1990

4.  Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.

Authors:  R Cherniak; H Valafar; L C Morris; F Valafar
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

5.  Dolichol phosphate mannose synthase is required in vivo for glycosyl phosphatidylinositol membrane anchoring, O mannosylation, and N glycosylation of protein in Saccharomyces cerevisiae.

Authors:  P Orlean
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

6.  Analysis of the neutral glycan fractions of glycosyl-phosphatidylinositols by thin-layer chromatography.

Authors:  P Schneider; J E Ralton; M J McConville; M A Ferguson
Journal:  Anal Biochem       Date:  1993-04       Impact factor: 3.365

7.  Biosynthesis of asparagine-linked oligosaccharides in Saccharomyces cerevisiae: the alg2 mutation.

Authors:  B J Jackson; M A Kukuruzinska; P Robbins
Journal:  Glycobiology       Date:  1993-08       Impact factor: 4.313

Review 8.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

Review 10.  Management of cryptococcosis.

Authors:  W E Dismukes
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

View more
  7 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.

Authors:  Laura S Chiapello; José L Baronetti; María P Aoki; Susana Gea; Héctor Rubinstein; Diana T Masih
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

Review 3.  The Cryptococcus neoformans capsule: a sword and a shield.

Authors:  Teresa R O'Meara; J Andrew Alspaugh
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 4.  Synthesis of cell envelope glycoproteins of Cryptococcus laurentii.

Authors:  John Schutzbach; Helmut Ankel; Inka Brockhausen
Journal:  Carbohydr Res       Date:  2007-01-12       Impact factor: 2.104

5.  Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade.

Authors:  Read Pukkila-Worley; Quincy D Gerrald; Peter R Kraus; Marie-Josée Boily; Matthew J Davis; Steven S Giles; Gary M Cox; Joseph Heitman; J Andrew Alspaugh
Journal:  Eukaryot Cell       Date:  2005-01

Review 6.  Virulence-Associated Enzymes of Cryptococcus neoformans.

Authors:  Fausto Almeida; Julie M Wolf; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2015-10-09

Review 7.  Virulence Factors as Targets for Anticryptococcal Therapy.

Authors:  Renata V D M Azevedo; Juliana Rizzo; Marcio L Rodrigues
Journal:  J Fungi (Basel)       Date:  2016-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.